Federica Mori
Overview
Explore the profile of Federica Mori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, et al.
Cell Discov
. 2024 Mar;
10(1):29.
PMID: 38480687
No abstract available.
2.
Lanini S, Capone S, Antinori A, Milleri S, Nicastri E, Camerini R, et al.
Sci Transl Med
. 2021 Oct;
14(627):eabj1996.
PMID: 34698501
Safe and effective vaccines against coronavirus disease 2019 (COVID-19) are essential for ending the ongoing pandemic. Although impressive progress has been made with several COVID-19 vaccines already approved, it is...
3.
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
Leoni G, DAlise A, Cotugno G, Langone F, Garzia I, De Lucia M, et al.
Cancer Res
. 2020 Jul;
80(18):3972-3982.
PMID: 32690723
Tumors with microsatellite instability (MSI) are caused by a defective DNA mismatch repair system that leads to the accumulation of mutations within microsatellite regions. Indels in microsatellites of coding genes...
4.
Esposito I, Cicconi P, DAlise A, Brown A, Esposito M, Swadling L, et al.
Sci Transl Med
. 2020 Jun;
12(548).
PMID: 32554708
Strategies to enhance the induction of high magnitude T cell responses through vaccination are urgently needed. Major histocompatibility complex (MHC) class II-associated invariant chain (Ii) plays a critical role in...
5.
Pulito C, Korita E, Sacconi A, Valerio M, Casadei L, Lo Sardo F, et al.
J Exp Clin Cancer Res
. 2019 Aug;
38(1):349.
PMID: 31399037
Background: Over the past decade, newly designed cancer therapies have not significantly improved the survival of patients diagnosed with Malignant Pleural Mesothelioma (MPM). Among a limited number of genes that...
6.
Paredi G, Mori F, De Marino M, Raboni S, Marchi L, Galati S, et al.
J Proteomics
. 2019 Jul;
206:103437.
PMID: 31271901
The impact of gender and diet on the proteome of Longissimus dorsi was addressed by 2D-PAGE analysis of male and female pigs, fed with a barley-based control diet and a...
7.
Belloni L, Di Cocco S, Guerrieri F, Nunn A, Piconese S, Salerno D, et al.
Sci Rep
. 2018 Sep;
8(1):13638.
PMID: 30206377
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. Although genetic predisposition and epigenetic factors contribute to the development of NAFLD, our understanding of the molecular...
8.
Chang K, Taggart M, Reyes-Uribe L, Borras E, Riquelme E, Barnett R, et al.
JAMA Oncol
. 2018 May;
4(8):1085-1092.
PMID: 29710228
Importance: Colorectal carcinomas in patients with Lynch syndrome (LS) arise in a background of mismatch repair (MMR) deficiency, display a unique immune profile with upregulation of immune checkpoints, and response...
9.
Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, et al.
Cell Discov
. 2017 Jul;
3:17022.
PMID: 28698800
Metformin is a commonly prescribed type II diabetes medication that exhibits promising anticancer effects. Recently, these effects were found to be associated, at least in part, with a modulation of...
10.
Mori F, Ferraiuolo M, Santoro R, Sacconi A, Goeman F, Pallocca M, et al.
Oncotarget
. 2016 Mar;
7(15):20532-48.
PMID: 26967561
We have previously shown that melatonin exerts tumor suppressor activities by inducing the p38-p53 axis. This occurred within a few hours while no data are available on how melatonin pathway...